SIT SELF-INSIGHT THERAPY
LIVE

Serial Number

79433311

Owner

VHEX Lab Co., Ltd.

Attorney

Jong Park

Filing Date

Aug 7, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SIT SELF-INSIGHT THERAPY Trademark

Serial Number: 79433311

SIT SELF-INSIGHT THERAPY is a trademark filed by VHEX Lab Co., Ltd. on August 7, 2025. The trademark is classified under Class 9 (Computers & Electronics). The application is currently pending registration.

Owner Contact Info

VHEX Lab Co., Ltd.

(Iui-dong, Gyeonggi XR Center) 603-604ho, 156 Gwanggyo-ro,

Entity Type: 03

Trademark Details

Filing Date

August 7, 2025

Registration Date

Not Registered

Published for Opposition

August 18, 2026

Goods & Services

Downloadable virtual reality software for psychological assessment; downloadable virtual reality software for psychological counseling; downloadable augmented reality software for psychological assessment; downloadable augmented reality software for psychological counseling; downloadable augmented reality software for mobile devices for psychological assessment and counseling

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 12, 2026 NONP
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 22, 2026 GNEN
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 22, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jul 22, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 22, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2026 TROA
REFUSAL PROCESSED BY IB
Feb 5, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 22, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 22, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 22, 2025 RFCR
NON-FINAL ACTION WRITTEN
Dec 21, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 29, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 25, 2025 REPR